Aethlon Medical

Aethlon Medical

Employees:
10
Market Cap:
$16.12 million
Revenue:
$392.07 thousand
5 Year Trend:
22.0%
Net Income:
$-6.05 million
NASDAQ:
AEMD

Aethlon Medical

Employees:
10
Market Cap:
$16.12 million
Revenue:
$392.07 thousand
5 Year Trend:
22.0%
Net Income:
$-6.05 million
NASDAQ:
AEMD
  • Feb 10 at 3:01 PM
    Our CEO James Joyce presented today at #BIOCEO16. Access the webcast replay here: http://bit.ly/1BLigxY
  • Dec 16 at 4:00 PM
    Tumor secreted exosomes represent a large unmet medical need in cancer, as they contribute to drug and chemotherapy resistance.
  • Dec 14 at 5:00 PM
    According to previous data, following the use of the Aethlon Hemopurifier for 6.5 hours, 242 million Ebola viruses were captured from a patient's blood.
  • Dec 11 at 7:00 PM
    The Aethlon Hemopurifier is a single-use device to clear viruses and tumor secreted exosomes from the blood.

Feb 10, 3:01 PM

Our CEO James Joyce presented today at #BIOCEO16. Access the webcast replay here: http://bit.ly/1BLigxY

Dec 16, 4:00 PM

Tumor secreted exosomes represent a large unmet medical need in cancer, as they contribute to drug and chemotherapy resistance.

Dec 14, 5:00 PM

According to previous data, following the use of the Aethlon Hemopurifier for 6.5 hours, 242 million Ebola viruses were captured from a patient's blood.

Dec 11, 7:00 PM

The Aethlon Hemopurifier is a single-use device to clear viruses and tumor secreted exosomes from the blood.